-
Something wrong with this record ?
Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment
H. Gisslinger, C. Klade, P. Georgiev, D. Krochmalczyk, L. Gercheva-Kyuchukova, M. Egyed, P. Dulicek, A. Illes, H. Pylypenko, L. Sivcheva, J. Mayer, V. Yablokova, K. Krejcy, V. Empson, HC. Hasselbalch, R. Kralovics, JJ. Kiladjian, PROUD-PV Study Group
Language English Country England, Great Britain
Document type Letter, Research Support, Non-U.S. Gov't
NLK
ProQuest Central
from 2000-01-01 to 1 year ago
Open Access Digital Library
from 1997-01-01
Nursing & Allied Health Database (ProQuest)
from 2000-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 2000-01-01 to 1 year ago
Public Health Database (ProQuest)
from 2000-01-01 to 1 year ago
- MeSH
- Progression-Free Survival MeSH
- Humans MeSH
- Polycythemia Vera * drug therapy MeSH
- Recombinant Proteins therapeutic use MeSH
- Check Tag
- Humans MeSH
- Publication type
- Letter MeSH
- Research Support, Non-U.S. Gov't MeSH
Clinic of Internal Medicine Hematology and Oncology University Hospital Brno Brno Czech Republic
Clinical Hematology Clinic Multiprofile Hospital for Active Treatment Sveta Marina Varna Bulgaria
Department of Clinical Hematology University Hospital Hradec Kralove Hradec Kralove Czech Republic
Department of Hematology Faculty of Medicine University of Debrecen Debrecen Hungary
Department of Hematology Yaroslavl Regional Clinical Hospital Yaroslavl Russia
Department of Internal Medicine 2 Kaposi Mor County Teaching Hospital Kaposvar Hungary
Department of Laboratory Medicine Medical University of Vienna Vienna Austria
Medical University of Plovdiv Plovdiv Bulgaria
Teaching Unit of the Hematology Department University Hospital in Krakow Krakow Poland
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24001152
- 003
- CZ-PrNML
- 005
- 20240213094407.0
- 007
- ta
- 008
- 240109s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41375-023-02008-6 $2 doi
- 035 __
- $a (PubMed)37634011
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Gisslinger, Heinz $u Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University Vienna, Vienna, Austria. heinz.gisslinger@meduniwien.ac.at
- 245 10
- $a Event-free survival in patients with polycythemia vera treated with ropeginterferon alfa-2b versus best available treatment / $c H. Gisslinger, C. Klade, P. Georgiev, D. Krochmalczyk, L. Gercheva-Kyuchukova, M. Egyed, P. Dulicek, A. Illes, H. Pylypenko, L. Sivcheva, J. Mayer, V. Yablokova, K. Krejcy, V. Empson, HC. Hasselbalch, R. Kralovics, JJ. Kiladjian, PROUD-PV Study Group
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a polycythaemia vera $x farmakoterapie $7 D011087
- 650 _2
- $a doba přežití bez progrese choroby $7 D000077982
- 650 _2
- $a rekombinantní proteiny $x terapeutické užití $7 D011994
- 655 _2
- $a dopisy $7 D016422
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Klade, Christoph $u AOP Health, Vienna, Austria
- 700 1_
- $a Georgiev, Pencho $u Medical University of Plovdiv, Plovdiv, Bulgaria
- 700 1_
- $a Krochmalczyk, Dorota $u Teaching Unit of the Hematology Department, University Hospital in Krakow, Krakow, Poland
- 700 1_
- $a Gercheva-Kyuchukova, Liana $u Clinical Hematology Clinic, Multiprofile Hospital for Active Treatment "Sveta Marina", Varna, Bulgaria
- 700 1_
- $a Egyed, Miklos $u Department of Internal Medicine II, Kaposi Mor County Teaching Hospital, Kaposvar, Hungary
- 700 1_
- $a Dulicek, Petr $u Department of Clinical Hematology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic
- 700 1_
- $a Illes, Arpad $u Department of Hematology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary
- 700 1_
- $a Pylypenko, Halyna $u Department of Hematology, Regional Treatment and Diagnostics Hematology Centre, Cherkasy Regional Oncology Centre, Cherkasy, Ukraine
- 700 1_
- $a Sivcheva, Lylia $u First Department of Internal Medicine, Multiprofile Hospital for Active Treatment - HristoBotev, Vratsa, Bulgaria
- 700 1_
- $a Mayer, Jiří $u Clinic of Internal Medicine - Hematology and Oncology, University Hospital Brno, Brno, Czech Republic
- 700 1_
- $a Yablokova, Vera $u Department of Hematology, Yaroslavl Regional Clinical Hospital, Yaroslavl, Russia
- 700 1_
- $a Krejcy, Kurt $u AOP Health, Vienna, Austria
- 700 1_
- $a Empson, Victoria $u AOP Health, Vienna, Austria $1 https://orcid.org/0000000338192370
- 700 1_
- $a Hasselbalch, Hans C $u Department of Hematology, Zealand University Hospital, Roskilde, University of Copenhagen, Copenhagen, Denmark $1 https://orcid.org/0000000339368032
- 700 1_
- $a Kralovics, Robert $u Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria $1 https://orcid.org/0000000269978539
- 700 1_
- $a Kiladjian, Jean-Jacques $u Université de Paris, AP-HP, Hôpital Saint-Louis, Centre d'Investigations Cliniques, INSERM, CIC1427, Paris, France $1 https://orcid.org/000000028121438X
- 710 2_
- $a PROUD-PV Study Group
- 773 0_
- $w MED00003138 $t Leukemia $x 1476-5551 $g Roč. 37, č. 10 (2023), s. 2129-2132
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37634011 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240109 $b ABA008
- 991 __
- $a 20240213094404 $b ABA008
- 999 __
- $a ok $b bmc $g 2049635 $s 1210846
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 37 $c 10 $d 2129-2132 $e 20230826 $i 1476-5551 $m Leukemia $n Leukemia $x MED00003138
- LZP __
- $a Pubmed-20240109
